31 Stocks Moving In Thursday’s Mid-Day Session
Gainers
TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results.
Axcella Therapeutics Details Clinical And Operational Milestones For 2022
Long COVID Phase 2a top-line data anticipated in mid-2022
EMMPACT℠ Phase 2b interim data in nonalcoholic steatohepatitis (NASH) anticipated in mid-2022
Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage
Axcella Therapeutics To Present At HC Wainwright BioConnect Conference Jan 10, 2022 At 7 a.m. EST
Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced that
Axcella Kickstarts Long COVID Phase 2 Clinical Trial
Axcella Therapeutics Inc (NASDAQ: AXLA) has
Axcella Therapeutics Announces Initiation Of AXA1125 Long COVID Phase 2a Clinical Trial
Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, and researchers at
Axcella Health Q3 EPS $(0.41) Down From $(0.34) YoY
Axcella Health (NASDAQ:AXLA) reported quarterly losses of $(0.41) per share. This is a 20.59 percent decrease over losses of $(0.34) per share from the same period last year.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Kiromic BioPharma (NASDAQ:KRBP) shares increased by 5.26% to $3.0 during Friday's after-market session. The market value of their outstanding shares is at $46.3 million.
